Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Development and manufacturing of genetic medicines, for purposes of reporting financial condition33.28M100.00%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United Kingdom33.28M100.00%